Company Overview - HeroSupport is a Swiss medical technology company founded in 2022, focusing on developing personalized fixation devices for prone breast cancer radiotherapy [2] - The company was established as a spin-off from the University Hospital of Geneva by Giovanna Dipasquale and Johan Uiterwijk, with Dipasquale serving as CEO and Uiterwijk as CTO [2] Technology and Innovation - HeroSupport utilizes proprietary imaging technology and advanced additive manufacturing to create customized fixation devices for prone breast cancer radiotherapy [6] - The imaging platform captures precise anatomical structures through surface scanning, allowing for the production of 3D-printed fixation devices tailored to each patient [6] - The fixation devices are made from medical-grade plastic and can be placed directly on the treatment table, facilitating patient positioning without the need for adjustments [6] Market Potential - The cancer radiotherapy market was valued at $6.6 billion in 2022 and is projected to reach $32 billion by 2032, with breast cancer accounting for 30% of all cancer cases [4] - Prone positioning in radiotherapy is noted to enhance treatment effectiveness, but maintaining consistent positioning remains a challenge [4] Clinical Impact - HeroSupport's devices aim to maximize the precision of prone radiotherapy while minimizing radiation exposure to healthy organs, significantly reducing the risk of collateral damage and secondary complications [7] - The treatment regimen can potentially be reduced from 15-25 sessions to just 5, allowing patients to complete treatment within a week and lowering healthcare costs [7] - The technology also reduces the risk of skin burns by 35% and the risk of lung and heart-induced tumors by 70% [7] Partnerships and Future Plans - HeroSupport has successfully completed a clinical trial and has secured paying customers [7] - In May 2025, the company will collaborate with the Swiss Medical Network to introduce its imaging platform and 3D-printed fixation devices in various oncology centers across Switzerland [7] - Future plans include targeting major radiotherapy centers in the EU, the US, and Australia [7] Recognition - HeroSupport has been listed among the 2024 TOP100 Swiss Startups, highlighting its innovative contributions to the Swiss technology landscape [9]